Trials / Completed
CompletedNCT03860870
Response to Clenbuterol in Humans
Detectability of Clenbuterol and Physiological Response in Human Skeletal Muscle
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Due to the long half-life (\~36 hr) of clenbuterol, detection methods such as dried blood spots (DBS) are a potentially suitable method to easily and non-invasively detect doping misuse of this compound for several days after ingestion. If, and how long, the compound can be detected by DBS has not yet been investigated but is of interest due to its potential in doping-control. The aim is to evaluate whether abuse of clenbuterol can be detected at relevant concentration levels in samples obtained using DBS and to assess the physiological response to clenbuterol in skeletal muscle..
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clenbuterol Oral Product | Subjects ingest 4x20 microgram clenbuterol tablets |
| DRUG | Placebo | Subjects ingest placebo tablets |
Timeline
- Start date
- 2019-03-11
- Primary completion
- 2022-12-21
- Completion
- 2022-12-21
- First posted
- 2019-03-04
- Last updated
- 2024-08-09
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03860870. Inclusion in this directory is not an endorsement.